2.05Open2.05Pre Close0 Volume30 Open Interest42.00Strike Price0.00Turnover58.46%IV-0.39%PremiumMay 16, 2025Expiry Date2.21Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6855Delta0.0902Gamma13.61Leverage Ratio-0.0646Theta-0.0076Rho-9.33Eff Leverage0.0240Vega
Revolution Medicines Stock Discussion
Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$